Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus rectal diclofenac for postpartum uterine cramping pain after vaginal delivery
PACTR202507562515638Phase 3Completed
- Sponsor
- Akingbala Omobolaji Oluseye
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of diclofenac (2 arms), sponsored by Akingbala Omobolaji Oluseye. Primary endpoint: Postpartum uterine cramping pain relief. Started Jun 2023; status: completed.
02
Drugs
diclofenac
Beyond the preview
Go deeper on PACTR202507562515638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202507562515638.